AbbVie Inc (ABBV)
Payables turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cost of revenue | US$ in thousands | 16,904,000 | 20,415,000 | 17,414,000 | 17,446,000 | 15,387,000 |
| Payables | US$ in thousands | — | — | — | — | — |
| Payables turnover | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue ÷ Payables
= $16,904,000K ÷ $—K
= —
Based on the data provided, the payables turnover ratio for AbbVie Inc is not available for the years 2020 to 2024. This could be due to a variety of reasons such as the data being unavailable, not disclosed, or potentially not applicable in the financial reporting of AbbVie Inc during these years.
The payables turnover ratio is a financial metric that is calculated by dividing the total purchases made by a company by its average accounts payable during a certain period. It is used to assess how efficiently a company is managing its payments to suppliers and creditors. Without specific figures for the payables turnover ratio, it is not possible to analyze the efficiency of AbbVie Inc in managing its accounts payables during the specified years.
Investors and stakeholders may consider engaging with AbbVie Inc directly or referring to their financial reports for more detailed information on their payables turnover and the management of their accounts payables for a clearer understanding of the company's financial performance and liquidity management.
Peer comparison
Dec 31, 2024